utilities

Archive | Our scientists

Scientist Focus: Prof Paul Brennan

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

Prof Paul Brennan is Head of Chemistry at the Alzheimer’s Research UK Oxford Drug Discovery Institute. What does your research focus on? As a medicinal chemist, my research is focused on finding new drugs for dementia. We design and make drug-like molecules and test them in cells that are engineered to behave like brain cells in […]

Scientist Focus: Dr Elena Di Daniel

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

Today (11 October) is Ada Lovelace Day, an international celebration of the work and achievements of women in science, technology, engineering and maths. To celebrate and showcase the work of the amazing women in dementia research, we caught up with Elena Di Daniel who is Head of Biology at the Alzheimer’s Research UK Oxford Drug […]

The immune system – a wolf in sheep’s clothing in Alzheimer’s?

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

Our immune systems are vital for keeping us healthy. This complex defence mechanism is made up of an army of millions of cells circulating in the blood and patrolling in our tissues. This army is made up of ‘battalions’ of cells with slightly different roles in identifying, alerting, destroying and clearing up damage in our […]

Tagged with:

Our new Chief Scientific Officer

Tim Parry

Dr David Reynolds joins Alzheimer’s Research UK in June as our new Chief Scientific Officer. What experience does David bring to the charity and how does he view the task ahead? We spoke to David as he takes up his new role. It was an unusual and slightly macabre moment of inspiration as a schoolboy […]

Read more

Scientist Focus: Dr Neil Oxtoby

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

Dr Neil Oxtoby from UCL (University College London) has just been awarded a little over £100,000 from Alzheimer’s Research UK and three other global international funders through an initiative called Biomarkers Across Neurodegenerative Diseases (BAND). BAND is supporting 11 international research projects to better characterise the similarities and differences between diseases like Alzheimer’s and Parkinson’s. […]

Tagged with:

Scientist Focus: Dr Rita Guerreiro

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

We’re delighted to announce that Dr Rita Guerreiro from University College London is the first ever winner of the Alzheimer’s Research UK Young Investigator of the Year Award. The Award celebrates excellence in dementia research and recognises the huge impact of Dr Guerreiro’s work across the world. In 2012, Dr Guerreiro and an international team […]

Tagged with:

The latest progress towards new dementia treatments

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

At Alzheimer’s Research UK, we’re committed to funding the most innovative grass-roots research and translating promising discoveries into benefits for people with dementia as quickly as possible. At the Alzheimer’s Research UK Conference 2016 in Manchester this week we’ve been hearing about some of the latest emerging research from across the UK. Where are we […]

Taking a closer look at blood flow in the brain

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

When talking about dementia we often focus on nerve cells – they are, after all, in charge of everything we do and think. But nerve cells aren’t lone rangers. Just like there’s no Sherlock Holmes without Watson, no Starsky without Hutch and no Ant without Dec, nerve cells and the blood vessels that supply the […]

What happens in the brain in dementia?

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneCatherine McKeeverKaty Stubbs

Not an easy question to answer, but researchers are moving closer to understanding what goes wrong with the circuitry of the brain in diseases like Alzheimer’s, frontotemporal dementia and dementia with Lewy bodies. In terms of complexity – one disease stands out more than others in the diversity of symptoms people can experience and the […]